FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2012144901> ?p ?o ?g. }

• W2012144901 endingPage "65" @default.
• W2012144901 startingPage "65" @default.
• W2012144901 abstract "Adjuvant chemoradiotherapy decreases the risk of local recurrence in patients with adenocarcinoma of the ampulla of Vater and high-risk features. Adjuvant chemoradiotherapy for this population can be administered safely and without much morbidity.Controlled, prospective, single-arm study.Tertiary care referral hospital.From June 1995 to March 1999, 12 patients (7 men and 5 women; median age, 66 years; age range, 38-78 years) with unfavorable ampullary carcinoma were treated with adjuvant chemoradiotherapy. All patients underwent pancreaticoduodenectomy, and all pathologic findings were confirmed at Stanford University Medical Center, Stanford, Calif. Unfavorable features were defined as involved lymph nodes (n = 10), involved surgical margins (n = 1), poorly differentiated histological features (n = 3), tumor size greater than 2 cm (n = 6), or the presence of neurovascular invasion (n = 4).Four to 6 weeks after undergoing pylorus-preserving pancreaticoduodenectomy with regional lymphadenectomy, patients began adjuvant chemoradiotherapy consisting of concurrent radiotherapy (45 Gy) and fluorouracil by protracted venous infusion (225-250 mg/m(2) per day, 7 days per week) for 5 weeks.Local recurrence, distant recurrence, overall survival rate, and treatment-related toxic effects.All patients completed the prescribed treatment course. Toxic effects were assessed twice a week during treatment and graded according to the National Cancer Institute Common Toxicity Criteria Scale. One patient required a treatment interruption of 1 week for grade III nausea/vomiting. No grade IV or V toxic effects were observed. At median follow-up of 24 months (range, 13-50 months), 8 of 12 patients were alive and disease free. One patient was alive but had disease recurrence. Three patients died of this disease (liver metastases). Actuarial overall survival at 2 years was 89%, and median survival was 34 months. One surviving patient developed a local recurrence and a lung lesion. Actuarial overall survival and median survival were better than in a parallel cohort with resected high-risk pancreatic cancer (n = 26) treated with the same adjuvant chemoradiotherapy regimen (median survival, 34 vs 14 months; P<.004).Adjuvant chemoradiotherapy for carcinoma of the ampulla of Vater is well tolerated and might improve control of this disease in patients with unfavorable features." @default.
• W2012144901 created "2016-06-24" @default.
• W2012144901 creator A5015065013 @default.
• W2012144901 creator A5027563495 @default.
• W2012144901 creator A5036188351 @default.
• W2012144901 creator A5055511966 @default.
• W2012144901 creator A5070367602 @default.
• W2012144901 creator A5078629816 @default.
• W2012144901 creator A5078696948 @default.
• W2012144901 date "2001-01-01" @default.
• W2012144901 modified "2023-09-27" @default.
• W2012144901 title "Adjuvant Chemoradiotherapy for Unfavorable Carcinoma of the Ampulla of Vater" @default.
• W2012144901 cites W1980390240 @default.
• W2012144901 cites W1982973371 @default.
• W2012144901 cites W1990177878 @default.
• W2012144901 cites W2045217572 @default.
• W2012144901 cites W2050842445 @default.
• W2012144901 cites W2057612022 @default.
• W2012144901 cites W2061342227 @default.
• W2012144901 cites W2066097107 @default.
• W2012144901 cites W2089086973 @default.
• W2012144901 cites W2090822967 @default.
• W2012144901 cites W2094428787 @default.
• W2012144901 cites W2115812130 @default.
• W2012144901 cites W2136235823 @default.
• W2012144901 cites W2141325015 @default.
• W2012144901 cites W2403816133 @default.
• W2012144901 cites W2482005349 @default.
• W2012144901 cites W2886755024 @default.
• W2012144901 cites W3025268722 @default.
• W2012144901 cites W46811911 @default.
• W2012144901 doi "https://doi.org/10.1001/archsurg.136.1.65" @default.
• W2012144901 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11146780" @default.
• W2012144901 hasPublicationYear "2001" @default.
• W2012144901 type Work @default.
• W2012144901 sameAs 2012144901 @default.
• W2012144901 citedByCount "53" @default.
• W2012144901 countsByYear W20121449012012 @default.
• W2012144901 countsByYear W20121449012013 @default.
• W2012144901 countsByYear W20121449012014 @default.
• W2012144901 countsByYear W20121449012015 @default.
• W2012144901 countsByYear W20121449012016 @default.
• W2012144901 countsByYear W20121449012017 @default.
• W2012144901 countsByYear W20121449012018 @default.
• W2012144901 countsByYear W20121449012019 @default.
• W2012144901 countsByYear W20121449012020 @default.
• W2012144901 countsByYear W20121449012021 @default.
• W2012144901 countsByYear W20121449012022 @default.
• W2012144901 crossrefType "journal-article" @default.
• W2012144901 hasAuthorship W2012144901A5015065013 @default.
• W2012144901 hasAuthorship W2012144901A5027563495 @default.
• W2012144901 hasAuthorship W2012144901A5036188351 @default.
• W2012144901 hasAuthorship W2012144901A5055511966 @default.
• W2012144901 hasAuthorship W2012144901A5070367602 @default.
• W2012144901 hasAuthorship W2012144901A5078629816 @default.
• W2012144901 hasAuthorship W2012144901A5078696948 @default.
• W2012144901 hasBestOaLocation W20121449011 @default.
• W2012144901 hasConcept C126322002 @default.
• W2012144901 hasConcept C141071460 @default.
• W2012144901 hasConcept C159110652 @default.
• W2012144901 hasConcept C2777546739 @default.
• W2012144901 hasConcept C2778424827 @default.
• W2012144901 hasConcept C2778975757 @default.
• W2012144901 hasConcept C2780580376 @default.
• W2012144901 hasConcept C2780840399 @default.
• W2012144901 hasConcept C2780852908 @default.
• W2012144901 hasConcept C2908647359 @default.
• W2012144901 hasConcept C509974204 @default.
• W2012144901 hasConcept C71924100 @default.
• W2012144901 hasConcept C90924648 @default.
• W2012144901 hasConcept C99454951 @default.
• W2012144901 hasConceptScore W2012144901C126322002 @default.
• W2012144901 hasConceptScore W2012144901C141071460 @default.
• W2012144901 hasConceptScore W2012144901C159110652 @default.
• W2012144901 hasConceptScore W2012144901C2777546739 @default.
• W2012144901 hasConceptScore W2012144901C2778424827 @default.
• W2012144901 hasConceptScore W2012144901C2778975757 @default.
• W2012144901 hasConceptScore W2012144901C2780580376 @default.
• W2012144901 hasConceptScore W2012144901C2780840399 @default.
• W2012144901 hasConceptScore W2012144901C2780852908 @default.
• W2012144901 hasConceptScore W2012144901C2908647359 @default.
• W2012144901 hasConceptScore W2012144901C509974204 @default.
• W2012144901 hasConceptScore W2012144901C71924100 @default.
• W2012144901 hasConceptScore W2012144901C90924648 @default.
• W2012144901 hasConceptScore W2012144901C99454951 @default.
• W2012144901 hasIssue "1" @default.
• W2012144901 hasLocation W20121449011 @default.
• W2012144901 hasLocation W20121449012 @default.
• W2012144901 hasOpenAccess W2012144901 @default.
• W2012144901 hasPrimaryLocation W20121449011 @default.
• W2012144901 hasRelatedWork W1485718295 @default.
• W2012144901 hasRelatedWork W1496967564 @default.
• W2012144901 hasRelatedWork W2100269289 @default.
• W2012144901 hasRelatedWork W2376132146 @default.
• W2012144901 hasRelatedWork W2387364079 @default.
• W2012144901 hasRelatedWork W2404562674 @default.
• W2012144901 hasRelatedWork W2581342907 @default.
• W2012144901 hasRelatedWork W2778716 @default.

• next